Encore Vision
Fort Worth
About Encore Vision
Encore Vision is developing a technology for the treatment of presbyopia. The company has been well-financed and mentored by ophthalmologists and optometrists during its incubation phase. Encore Vision has achieved significant progress in developing extensive Intellectual Property protection. Encore Vision’s technology is covered by a robust and growing patent portfolio which includes one issued broad-based US patent, a notice of allowance on a second U.S. patent, and more than 40 Pending the US and foreign patent applications and provisional filings, including the composition of matter applications for its proprietary formulations. The company has completed in-vivo proof of concept in an animal model for presbyopia and has begun development activities leading to clinical studies in man. It was established in 2000 and is headquartered in Fort Worth, Texas.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $12.0M
- Funding stage: M&A
- Last round: Series Unknown (May 2016)
- Website: encorevisioninc.com
- Phone: 5094872251
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/encore-vision-152670 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.